Schedule 13G ownership disclosure
CRESCENT BIOPHARMA INC.
Ordinary Shares, $0.001 par value per share · CUSIP: G2545C104
Event date: 2025-12-08
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ForGrowth III PA B.V.
Shares: 1,677,852 · Class: 6.1%
- Forbion Growth Opportunities Fund III Cooperatief U.A.
Shares: 1,677,852 · Class: 6.1%
- Forbion Growth III Management B.V.
Shares: 1,677,852 · Class: 6.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-315863
- Form type
- SCHEDULE 13G
- Filer
- CRESCENT BIOPHARMA, INC.
- CIK
- CIK 1253689
- Filed
- Dec 11, 2025
- Reporting period
- Dec 08, 2025
- Description
- Schedule 13G beneficial ownership